Moreover, since adipogenesis [42], insulin resistance [32] and oxidative stress have an important role in NAFLD development [43], proliferator-activated receptor gamma (PPARγ), a downstream mediator of the WNT cascade, is likely involved in the prevention of NASH progression [7,44]. The gene discussed is PPARG; the disease is metabolic dysfunction-associated steatotic liver disease.